Endoplasmic reticulum: nutrient sensor in physiology and pathology

Trends in Endocrinology and Metabolism

Volumn 20, Issue 4, 2009, Pages 194-201

  Mandl, József ^a,b   Mészáros, Tamás ^a,b   Bánhegyi, Gábor ^a,b   Hunyady, László ^a   Csala, Miklós ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIDINE NUCLEOTIDE;

CELL ORGANELLE; CHOLESTEROL SYNTHESIS; ENDOPLASMIC RETICULUM; ENVIRONMENTAL CHANGE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; SENSOR; STRESS;

AMINO ACIDS; ANIMALS; CHOLESTEROL; ENDOPLASMIC RETICULUM; HUMANS; INSULIN; PYRIMIDINE NUCLEOTIDES; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 65249133510     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2009.01.003     Document Type: Review

References (75)

1. Csala M., et al. Transport and transporters in the endoplasmic reticulum. Biochim. Biophys. Acta 1768 (2007) 1325-1341
2. Csala M., et al. Endoplasmic reticulum: a metabolic compartment. FEBS Lett. 580 (2006) 2160-2165
3. van Anken E., and Braakman I. Versatility of the endoplasmic reticulum protein folding factory. Crit. Rev. Biochem. Mol. Biol. 40 (2005) 191-228
4. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8 (2007) 519-529
5. Scheuner D., and Kaufman R.J. The unfolded protein response: a pathway that links insulin demand with β-cell failure and diabetes. Endocr. Rev. 29 (2008) 317-333
6. 2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 32 (2002) 269-278
7. Iyanagi T. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification. Int. Rev. Cytol. 260 (2007) 35-112
8. Ghosh D. Human sulfatases: a structural perspective to catalysis. Cell. Mol. Life Sci. 64 (2007) 2013-2022
9. Csala M., et al. Beta-glucuronidase latency in isolated murine hepatocytes. Biochem. Pharmacol. 59 (2000) 801-805
10. Odermatt A., et al. Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11β-HSD1. Mol. Cell. Endocrinol. 248 (2006) 15-23
11. Hwang C., et al. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257 (1992) 1496-1502
12. Piccirella S., et al. Uncoupled redox systems in the lumen of the endoplasmic reticulum. Pyridine nucleotides stay reduced in an oxidative environment. J. Biol. Chem 281 (2006) 4671-4677
13. Liscum L., et al. 3-Hydroxy-3-methylglutaryl-CoA reductase: a transmembrane glycoprotein of the endoplasmic reticulum with N-linked "high-mannose" oligosaccharides. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 7165-7169
14. DeBose-Boyd R.A. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18 (2008) 609-621
15. Doolman R., et al. Ubiquitin is conjugated by membrane ubiquitin ligase to three sites, including the N terminus, in transmembrane region of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for sterol-regulated enzyme degradation. J. Biol. Chem. 279 (2004) 38184-38193
16. Song B.L., et al. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol. Cell 19 (2005) 829-840
17. Raghow R., et al. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol. Metab. 19 (2008) 65-73
18. Jump D.B., et al. Fatty acid regulation of hepatic gene transcription. J. Nutr. 135 (2005) 2503-2506
19. Foufelle F., and Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366 (2002) 377-391
20. Kolehmainen M., et al. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes. Res. 9 (2001) 706-712
21. Feng W., et al. Transmembrane redox sensor of ryanodine receptor complex. J. Biol. Chem. 275 (2000) 35902-35907
22. 2+ release mechanism. J. Biol. Chem 272 (1997) 7069-7077
23. Kaplin A.I., et al. Purified reconstituted inositol 1,4,5-trisphosphate receptors. Thiol reagents act directly on receptor protein. J. Biol. Chem 269 (1994) 28972-28978
24. Higo T., et al. Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44. Cell 120 (2005) 85-98
25. Lavery G.G., et al. Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. J. Biol. Chem. 283 (2008) 8453-8461
26. Callebaut I., et al. Redox mechanism for the chaperone activity of heat shock proteins HSPs 60, 70 and 90 as suggested by hydrophobic cluster analysis: hypothesis. Comptes Rendus de l'Academie des Sciences 317 (1994) 721-729
27. Papp E., et al. Molecular chaperones, stress proteins and redox homeostasis. Biofactors 17 (2003) 249-257
28. Papp E., et al. Changes of endoplasmic reticulum chaperone complexes, redox state, and impaired protein disulfide reductase activity in misfolding α1-antitrypsin transgenic mice. FASEB J. 20 (2006) 1018-1020
29. Lavery G.G., et al. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J. Biol. Chem. 281 (2006) 6546-6551
30. + and is stimulated by extracellular glucose. Mol. Cell. Endocrinol. 301 (2009) 137-141
31. Pattingre S., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005) 927-939
32. 2+ homeostasis and apoptosis. EMBO J. 23 (2004) 1207-1216
33. Wei Y., et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30 (2008) 678-688
34. Elouil H., et al. Acute nutrient regulation of the unfolded protein response and integrated stress response in cultured rat pancreatic islets. Diabetologia 50 (2007) 1442-1452
35. Greenman I.C., et al. Distinct glucose-dependent stress responses revealed by translational profiling in pancreatic β-cells. J. Endocrinol. 192 (2007) 179-187
36. Cunha D.A., et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 121 (2008) 2308-2318
37. Hou Z.Q., et al. Involvement of chronic stresses in rat islet and INS-1 cell glucotoxicity induced by intermittent high glucose. Mol. Cell. Endocrinol. 291 (2008) 71-78
38. Gonzales J.C., et al. Chemical induction of the unfolded protein response in the liver increases glucose production and is activated during insulin-induced hypoglycaemia in rats. Diabetologia 51 (2008) 1920-1929
39. Ji C., and Kaplowitz N. ER stress: can the liver cope?. J. Hepatol. 45 (2006) 321-333
40. Pirot P., et al. Transcriptional regulation of the endoplasmic reticulum stress gene chop in pancreatic insulin-producing cells. Diabetes 56 (2007) 1069-1077
41. Kharroubi I., et al. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145 (2004) 5087-5096
42. Kaneto H., et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int. J. Biochem. Cell Biol. 38 (2006) 782-793
43. Laybutt D.R., et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50 (2007) 752-763
44. Herbach N., et al. Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice. Diabetes 56 (2007) 1268-1276
45. Huang C.J., et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56 (2007) 2016-2027
46. Stoy J., et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15040-15044
47. Marchetti P., et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50 (2007) 2486-2494
48. Song B., et al. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J. Clin. Invest. 118 (2008) 3378-3379
49. Kahn S.E., et al. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006) 840-846
50. Prentki M., and Nolan C.J. Islet beta cell failure in type 2 diabetes. J. Clin. Invest. 116 (2006) 1802-1812
51. Wang H., et al. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J. Cell Sci. 118 (2005) 3905-3915
52. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279 (2004) 42351-42354
53. Kaniuk N.A., et al. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 56 (2007) 930-939
54. Ozcan U., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
55. Sharma N.K., et al. Endoplasmic reticulum stress markers are associated with obesity in non-diabetic subjects. J. Clin. Endocrinol. Metab. 93 (2008) 4532-4541
56. Hausman D.B., et al. The biology of white adipocyte proliferation. Obes. Rev. 2 (2001) 239-254
57. Hosogai N., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56 (2007) 901-911
58. 307. J. Biol. Chem. 275 (2000) 9047-9054
59. Hirosumi J., et al. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
60. Gregor M.F., and Hotamisligil G.S. Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J. Lipid Res 48 (2007) 1905-1914
61. Senesi S., et al. Constant expression of hexose-6-phosphate dehydrogenase during differentiation of human adipose-derived mesenchymal stem cells. J. Mol. Endocrinol. 41 (2008) 125-133
62. Marcolongo P., et al. Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum. Biochem. Pharmacol. 76 (2008) 382-390
63. Koumenis C., and Wouters B.G. "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol. Cancer Res. 4 (2006) 423-436
64. Cawthorn W.P., and Sethi J.K. TNF-α and adipocyte biology. FEBS Lett. 582 (2008) 117-131
65. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
66. Houstis N., et al. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
67. Zhang K., and Kaufman R.J. From endoplasmic-reticulum stress to the inflammatory response. Nature 454 (2008) 455-462
68. de Ferranti S., and Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem. 54 (2008) 945-955
69. Nebert D.W. Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol. 5 (1991) 1203-1214
70. Miller W.L. Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 146 (2005) 2544-2550
71. White P.C., et al. Physiological roles of 11 beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase. Curr. Opin. Pediatr. 20 (2008) 453-457
72. Wamil M., and Seckl J.R. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov. Today 12 (2007) 504-520
73. Lum J.J., et al. Autophagy in metazoans: cell survival in the land of plenty. Nat. Rev. Mol. Cell Biol. 6 (2005) 439-448
74. Kruse K.B., et al. Autophagy: an ER protein quality control process. Autophagy 2 (2006) 135-137
75. Levine B., and Kroemer G. Autophagy in the pathogenesis of disease. Cell 132 (2008) 27-42